<DOC>
	<DOC>NCT00862888</DOC>
	<brief_summary>The purpose of this study is to investigate the effect of up to 200 mg of PF-00446687 on erectile activity in males suffering from erectile dysfunction as well as examining the safety and toleration of the drug.</brief_summary>
	<brief_title>Study to Investigate Effect of a New Drug (PF-00446687) in Males Suffering From Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Males aged 1865 years who has given written informed consent to participate in the study and who suffers moderate to severe erectile dysfunction who has a current or recent successful response to treatment with phosphodiesterase type 5 inhibitors Males with a history of significant cardiac disease; unstable angina or recent myocardial infarction. Males suffering from treated or untreated hypo or hypertension Males currently receiving vasoactive medication Males taking medications contraindicated, or cautioned with sildenafil or MC4 agonists</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>